Inflammatory Signatures Associated with Obesity in Patients with Stage II Breast Cancer Receiving Doxorubicin- Cyclophosphamide Therapy
Background: Obesity is being considered as a biological factor in altering the progression of breast cancer, as well as potentially influencing the response to treatment. It is marked by persistent low-level systemic inflammation mediated by adipose tissue-derived adipokines and cytokines, which can affect the tumor mi...